I was under the impression that they were initially allowed to produce the drugs since they were on FDA drug shortage lists. As expected, the compounders scaled up their pipelines to meet demand and now that the drugs have been taken off the shortage list the compounders are incentivized to figure out how to keep things legal. (Of course, they should have had clean supply chains this whole time.)
I'm curious if one of these outfits got bought out to end the supply shortage.
Has AWS support gone downhill in the last two years? I've worked with them in the past - as both an individual and a couple startups - I always reached a human. Issues weren't always resolved as quickly as I'd like but response times were short.
https://web.archive.org/web/20080521163217/http://www.time.c...